arrow
M

Mark Muthiah

National University of Singapore
H指数:50
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Global ACLF Consensus : the ‘Istanbul Document’

全球ACLF共识:伊斯坦布尔文件

2026-09-240
PRE
Delphi survey to explore core curriculum for training the next generation of hepatologists

德尔菲调查探索下一代肝病学家培训的核心课程

2026-08-010
PRE
The global cardiovascular-kidney-liver-metabolic burden from 1990 to 2023

1990年至2023年全球心血管-肾脏-肝脏-代谢负担

2026-08-010
OAAI
A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper

全球关于急性-on-慢性肝衰竭患者重症监护管理的共识:APASL ACLF北京立场文件

2026-07-300
PRE
Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver Disease

酒精相关肝病患者临床和心血管代谢结局中的种族差异

2026-05-160
PRE
Rising burden of metabolic dysfunction-associated steatotic liver disease in adolescents aged 15–19 years and projections to 2035

15~19岁青少年代谢功能障碍相关脂肪性肝病的负担日益加重及至2035年的预测

2025-11-170
PRE
Waitlist and Post-Transplant Outcomes in Liver Transplantation for Alcohol-Associated Liver Disease: An Individual Patient Data Meta-Analysis

酒精性肝病肝移植的候补名单及移植后结局:一项个体患者数据Meta分析

2025-10-310
PRE
Impact of MELD 3.0 on Waitlist Outcomes of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates

MELD 3.0对代谢功能障碍相关脂肪性肝炎肝硬化等待移植患者等待名单结局的影响

2025-10-250
PRE
Meta-Analysis: Utilisation of Hepatocellular Carcinoma Surveillance

Meta-Analysis: 肝细胞癌筛查的应用

2025-10-120
PRE
Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH

靶向抑制肝脏从头合成鞘氨醇抑制MASH

2025-09-260
PRE
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-Analysis

代谢功能障碍相关脂肪性肝病中肝细胞癌的发生率:一项重建的个体患者数据荟萃分析

2025-09-090
PRE
Dysbiosis-Driven Reprogramming of Secondary Bile Acid Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights from an Ex Vivo Human Fecal Microbiota Model

菌群失调驱动的继发性胆汁酸代谢重编程在代谢功能障碍相关脂肪性肝病中的研究:源自体外人类粪便微生物群模型的见解

2025-09-010
PRE
Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis

基于体成分分析的代谢功能障碍相关脂肪性肝病的肝脏脂肪变量化评估

2025-08-300
OAAI